Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Common Warts Market?

Over the past few years, the market size for common warts has seen substantial growth. Anticipated to surge from $2.13 billion in 2024 to $2.25 billion in 2025, it will exhibit a compound annual growth rate (CAGR) of 5.9%. The surge during this historic period can be credited to an escalated consciousness about skin health, a heightened occurrence of warts, a rising preference for non-invasive processes, a hike in the usage of cryotherapy, and expansion in dermatological clinics.

Expectations are high for substantial expansion of the common warts market size in the upcoming years. The market is projected to increase to $2.81 billion in 2029, with a compound annual growth rate (CAGR) of 5.7%. Various factors are contributing to this expected growth during the forecast period, including an ageing population, increased instances of viral infections, a wider acceptance of cutting-edge dermatological therapies, rising demand for individualized treatments and a heightened consumer preference for homecare solutions. Key trends for the forecast period constitute progress in dermatological treatments, growth of healthcare infrastructure, technological innovations in wart removal treatments, an improvement in awareness of treatment possibilities and a move towards minimally invasive treatments.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21154&type=smp

What Drivers Are Accelerating Expansion Of The Common Warts Market?

The projected growth of the common warts market is largely attributed to the escalating incidence of viral infections. Viruses are responsible for certain illnesses as they invade, multiply, and spread within the body, consequently affecting cellular function and immune responses. Factors such as globalization, climate change, urbanization, deforestation, and weakened immune systems drive the increase in viral infections. The focus of common warts treatment is the human papillomavirus (HPV), which causes wart formation. Treatment aims to support individuals with viral infections by limiting virus transmission, providing relief from discomfort, promoting healing, and preventing complications like secondary infections or scarring, ultimately enhancing the patient’s quality of life. For example, the Centers for Disease Control and Prevention, a US-based government agency, indicated in 2024 that there was a 62% increase in PCR-confirmed varicella cases from 29% to 47% over the previous five years in 2022. Additionally, as per the National Foundation for Infectious Diseases, another US-based health organization, it was reported in January 2023 that the United States witnesses an estimated 14 million new HPV infections annually. As a result, the continued rise in viral infections serves as a catalyst for the growth of the common warts market.

What Are The Primary Segmentation Parameters In The Common Warts Market?

The common wartsmarket covered in this report is segmented –

1) By Treatment Method: Cryotherapy; Laser Treatment; Electrosurgery; Topical Medications

2) By Patient Demographics: Children; Adults; Elderly

3) By Disease Stage: Initial Stage; Moderate Stage; Severe Stage

4) By End User: Hospitals; Dermatology Clinics; Home Care

Subsegments:

1) By Cryotherapy: Liquid Nitrogen Therapy; Carbon Dioxide Therapy

2) By Laser Treatment: Pulsed-Dye Laser Therapy; Carbon Dioxide (CO2) Laser Therapy

3) By Electrosurgery: Curettage And Electrosurgical Removal; High-Frequency Electrosurgical Ablation

4) By Topical Medications: Salicylic Acid-Based Therapy; Immunotherapy-Based Topicals; Retinoid-Based Therapy

Which Emerging Trends Are Reshaping The Common Warts Market Landscape?

Key players in the common warts market are concentrating their efforts on developing innovative treatments such as dermatological therapies to cater to the rising demand for effective and easily accessible remedies. The goal is to improve patient outcomes and increase their foothold in the dermatology industry. Dermatological therapies comprise treatments for various skin conditions including infections, inflammations, and disorders. To illustrate, Verrica Pharmaceuticals, a company based in the US, entered into a licensing agreement with Torii Pharmaceutical Co. Ltd., a company based in Japan, in May 2024. The partnership was aimed at financing a global Phase 3 clinical trial for YCANTH, a treatment option for common warts. This partnership encourages the late-stage development of YCANTH, thereby broadening its potential global scope. Torii Pharmaceuticals will provide financial backing for the progression of the study. This alliance enhances both firms’ dermatology portfolios and strengthens their international market standing.

Which Players Are Shaping The Competitive Landscape Of The Common Warts Market?

Major companies operating in the common warts market are Major players in the market are AbbVie Inc., GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Perrigo Company plc, Holland & Barrett International Limited, Prestige Consumer Healthcare Inc., Maruho Co. Ltd., Novan Inc., X4 Pharmaceuticals Inc., Aclaris Therapeutics Inc., Verrica Pharmaceuticals Inc., RXi Pharmaceuticals Corporation, Scholl’s Wellness Company, Nielsen BioSciences Inc., Cassiopea S.p.A., Orgenesis Inc., KinoPharma Inc., Naturasil, Veradermics Inc., KinoPharma Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/common-warts-global-market-report

What Are The Emerging Regional Trends Driving The Common Warts Market?

North America was the largest region in the common warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the common warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21154&type=smp

Browse Through More Reports Similar to the Global Common Warts Market 2025, By The Business Research Company

Warts Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Hpv Associated Disorders Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hpv-associated-disorders-global-market-report

Hpv Testing And Pap Test Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hpv-testing-and-pap-test-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model